WallStSmart

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD)vsWellgistics Health, Inc. Common Stock (WGRX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Wellgistics Health, Inc. Common Stock generates 15% more annual revenue ($23.34M vs $20.31M). WGRX leads profitability with a 0.0% profit margin vs -0.1%. HKPD earns a higher WallStSmart Score of 36/100 (F).

HKPD

Hold

36

out of 100

Grade: F

Growth: 7.3Profit: 2.5Value: 5.0Quality: 5.0

WGRX

Avoid

30

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 5.0Quality: 5.0

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HKPD2 strengths · Avg: 10.0/10
Price/BookValuation
1.5x10/10

Reasonable price relative to book value

EPS GrowthGrowth
130.2%10/10

Earnings expanding 130.2% YoY

WGRX0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

HKPD4 concerns · Avg: 2.3/10
Market CapQuality
$6.99M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-0.6%2/10

ROE of -0.6% — below average capital efficiency

Revenue GrowthGrowth
-4.7%2/10

Revenue declined 4.7%

Free Cash FlowQuality
$-106,3932/10

Negative free cash flow — burning cash

WGRX4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$10.44M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-9.3%2/10

ROE of -9.3% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : HKPD

The strongest argument for HKPD centers on Price/Book, EPS Growth.

Bull Case : WGRX

WGRX has a balanced fundamental profile.

Bear Case : HKPD

The primary concerns for HKPD are Market Cap, Return on Equity, Revenue Growth.

Bear Case : WGRX

The primary concerns for WGRX are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

HKPD profiles as a turnaround stock while WGRX is a value play — different risk/reward profiles.

HKPD is growing revenue faster at -4.7% — sustainability is the question.

HKPD generates stronger free cash flow (-106,393), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HKPD scores higher overall (36/100 vs 30/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Hong Kong Pharma Digital Technology Holdings Limited is a pioneering company at the intersection of biotechnology and digital healthcare, focusing on the integration of cutting-edge technology with pharmaceutical services to enhance patient outcomes and streamline healthcare delivery. Leveraging advanced digital solutions and data analytics, the company optimizes drug development processes and improves operational efficiencies, positioning itself as a critical player in the evolving healthcare landscape. With a strong commitment to health technology advancement and the cultivation of strategic alliances, Hong Kong Pharma is poised to meet the demands of both domestic and global markets while driving innovation across its pharmaceutical service offerings.

Wellgistics Health, Inc. Common Stock

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Wellgistics Health, Inc. is a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company is headquartered in Tampa, Florida.

Want to dig deeper into these stocks?